
Boston (DbTechNo) – The FDA (Food and Drug Administration) have just approved an antipsychotic drug made by Eli Lilly for use in Teenagers.
Zyprexa is the name of the blockbuster drug which even before this approval was the best selling drug for the company.
The drug has just been approved to treat teens diagnosed with schizophrenia and manic depression, despite the possible severe weight gain side effect.
The drug has been approved in a lesser dose for teens than it is currently approved for in adults, and the label recommends that the drug be just part of a “total treatment program for teens with schizophrenia and bipolar I disorder.”
Last year, sales of Zyprexa topped 4.7 billion dollars, a number that will skyrocket now that the drug has gained further approval.
Upon news of the FDA approval shares of Eli Lilly jumped by 49 cents to $37.88.
Eli Lilly sells a drug (Zyprexa) that can cause diabetes and then turn a profit on the drugs that treat the condition that they may have caused in the first place!
Eli Lilly has made $38 billion on Zyprexa and it was way oversold and caused diabetes and in some cases sudden death.
Eli Lilly has received a huge criminal fine over their Zyprexa cash cow,add it all up comes to $4.6 billion, in Zyprexa settlements,fines,litigation.
Did you know that Lilly made $ billions last year on diabetic meds, Actos,Humulin and Byetta?
They sell a drug that can cause diabetes and then turn a profit on the drugs that treat the condition that they may have caused in the first place!
—-
Daniel Haszard Zyprexa whistle-blower http://www.zyprexa-victims.com